Sometimes the heat makes you vomit, said Carmen Garcia, a farmworker in the San Joaquin Valley of California. She and her husband spent July in the garlic fields, kneeling on the scorched earth as temperatures hovered above 105 degrees.
Johnson & Johnson seeks FDA approval for Tremfya for Crohn’s
The GRAVITI study evaluated guselkumab induction therapy. Credit: peterschreiber.media/Shutterstock. Johnson & Johnson (J&J) has submitted a supplemental biologics licence application (sBLA) seeking approval from the
June 21, 2024